These findings suggest that miR-16-5p, which plays an anticancer role, was expressed at low levels while ANLN was overexpressed in BC cells compared with normal cells and that miR-16-5p could be tightly associated with phenotypic changes in breast carcinoma by targeting ANLN. Here, ANLN is linked to breast cancer.